Becton Dickinson and Co (BDX):企業の財務・戦略的SWOT分析

◆英語タイトル:Becton Dickinson and Co (BDX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME511FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年2月
◆ページ数:82
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥35,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥52,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Becton Dickinson and Co (BDX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Becton Dickinson and Co (BD) is a medical technology company that manufactures and sells medical devices, reagents and instruments. Its major products include syringes and pen needles; intravenous catheters; infusion pumps and disposables; automated medication dispensing and supply management systems; pre-fillable drug delivery systems; respiratory ventilation and diagnostics equipment and consumables; products for the safe collection and transport of diagnostics specimens; instruments and reagent systems to detect a broad range of infectious diseases, and cancers and various clinical research tools. BD offers its products to life science researchers, healthcare institutions, clinical laboratories, pharmaceutical industry and general public. The company sells its products in the Americas, Europe, the Middle East, Africa and Asia-Pacific. BD is headquartered in New Jersey, the US.

Becton Dickinson and Co Key Recent Developments

Feb 22,2021: BD and Scanwell Health partner to create at-home SARS-CoV-2 test
Feb 10,2021: Dev Kurdikar Named President of BD Diabetes Care
Feb 04,2021: BD announces first fiscal quarter results; Raises fiscal 2021 guidance
Feb 02,2021: First-of-its-kind randomized clinical trial published in “The Lancet Infectious Diseases” outlines potential new standard-setting best practices for peripheral IV catheters
Jan 28,2021: BD named a Best Place to Work for LGBTQ Equality for fourth consecutive year

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Becton Dickinson and Co – Key Facts
Becton Dickinson and Co – Key Employees
Becton Dickinson and Co – Key Employee Biographies
Becton Dickinson and Co – Major Products and Services
Becton Dickinson and Co – History
Becton Dickinson and Co – Company Statement
Becton Dickinson and Co – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Business Unit
Section 2 – Company Analysis
Company Overview
Becton Dickinson and Co – Business Description
Business Segment: BD Interventional
Overview
Performance
Business Segment: BD Life Sciences
Overview
Performance
Business Segment: BD Medical
Overview
Performance
Geographical Segment: Europe
Target Markets
Performance
Geographical Segment: Greater Asia
Target Markets
Performance
Geographical Segment: Others
Target Markets
Performance
Geographical Segment: The US
Performance
R&D Overview
Becton Dickinson and Co – Corporate Strategy
Becton Dickinson and Co – SWOT Analysis
SWOT Analysis – Overview
Becton Dickinson and Co – Strengths
Becton Dickinson and Co – Weaknesses
Becton Dickinson and Co – Opportunities
Becton Dickinson and Co – Threats
Becton Dickinson and Co – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences, Power Financial Deals and Alliances
Becton Dickinson and Co, Medical Equipment, Deals By Year, 2015 to YTD 2021
Becton Dickinson and Co, Medical Equipment, Deals By Type, 2015 to YTD 2021
Becton Dickinson and Co, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 22, 2021: BD and Scanwell Health partner to create at-home SARS-CoV-2 test
Feb 10, 2021: Dev Kurdikar Named President of BD Diabetes Care
Feb 04, 2021: BD announces first fiscal quarter results; Raises fiscal 2021 guidance
Feb 02, 2021: First-of-its-kind randomized clinical trial published in “The Lancet Infectious Diseases” outlines potential new standard-setting best practices for peripheral IV catheters
Jan 28, 2021: BD named a Best Place to Work for LGBTQ Equality for fourth consecutive year
Jan 26, 2021: BD names CEO Tom Polen as Chairman of the Board
Jan 12, 2021: BD provides updates to its fiscal 2021 financial outlook and intends to comment on its preliminary first fiscal quarter revenue performance during today’s webcast At The 39th Annual J.P. Morgan Healthcare Conference
Dec 17, 2020: BD: Focusing on the future: setting Climate Change targets
Dec 16, 2020: BD surpasses 1 billion injection device orders in support of COVID-19 vaccination efforts around the world
Dec 14, 2020: BD publishes its inaugural cybersecurity annual report
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Becton Dickinson and Co, Key Facts
Becton Dickinson and Co, Key Employees
Becton Dickinson and Co, Key Employee Biographies
Becton Dickinson and Co, Major Products and Services
Becton Dickinson and Co, History
Becton Dickinson and Co, Other Locations
Becton Dickinson and Co, Subsidiaries
Becton Dickinson and Co, Business Unit
Becton Dickinson and Co, Key Competitors
Becton Dickinson and Co, Ratios based on current share price
Becton Dickinson and Co, Annual Ratios
Becton Dickinson and Co, Annual Ratios (Cont...1)
Becton Dickinson and Co, Annual Ratios (Cont...2)
Becton Dickinson and Co, Interim Ratios
Becton Dickinson and Co, Medical Equipment, Deals By Year, 2015 to YTD 2021
Becton Dickinson and Co, Medical Equipment, Deals By Type, 2015 to YTD 2021
Becton Dickinson and Co, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Becton Dickinson and Co (BDX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Johnny Rockets Group, Inc.:企業の戦略・SWOT・財務情報
    The Johnny Rockets Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Johnny Rockets Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • PetroChina Company Limited:企業の戦略・SWOT・財務分析
    PetroChina Company Limited - Strategy, SWOT and Corporate Finance Report Summary PetroChina Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • CEL-SCI Corp (CVM):企業の財務・戦略的SWOT分析
    CEL-SCI Corp (CVM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • INRIX, Inc.:企業の戦略・SWOT・財務情報
    INRIX, Inc. - Strategy, SWOT and Corporate Finance Report Summary INRIX, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Quadrise Fuels International Plc (QFI)-石油・ガス分野:企業M&A・提携分析
    Summary Quadrise Fuels International Plc (QFI), formerly Zareba Plc, is an oil-in-water emulsified fuel developer that manufactures and markets MSAR (Multiphase Superfine Atomised Residue), an emulsion fuel as a low cost substitute for conventional heavy fuel oil (HFO) for use in power generation pl …
  • Etam Developpement SCA:企業の戦略・SWOT・財務情報
    Etam Developpement SCA - Strategy, SWOT and Corporate Finance Report Summary Etam Developpement SCA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • CITIC Resources Holdings Limited:企業の戦略・SWOT・財務情報
    CITIC Resources Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary CITIC Resources Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Citrix Systems Inc (CTXS):企業の財務・戦略的SWOT分析
    Citrix Systems Inc (CTXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • PDL BioPharma Inc (PDLI)-製薬・医療分野:企業M&A・提携分析
    Summary PDL BioPharma Inc (PDL) formerly Protein Design Labs, Inc., manages a portfolio of patents and royalty assets that include Queen et al. patents and license agreements with various pharmaceutical and biotechnology companies, and royalty and other acquired assets. It offers financing solutions …
  • Olmsted Medical Center-製薬・医療分野:企業M&A・提携分析
    Summary Olmsted Medical Center (OMC) is a healthcare service provider that offers patient care and clinical research services. The center offers services in the areas of general surgery, podiatry, pain management, dermatology, plastic surgery, inpatient dietary services, pediatrics, diabetes educati …
  • Symbiotec Pharmalab Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Symbiotec Pharmalab Ltd (Symbiotec) is a medical laboratory that manufactures active pharmaceutical ingredients. The laboratory develops, produces and markets research-based cortico steroids and steroid-hormone APIs. Its cortico-steroids APIs include clobetasol propionate, betamethasone dipr …
  • Parker Hannifin Corporation (PH)-医療機器分野:企業M&A・提携分析
    Summary Parker Hannifin Corporation (Parker) is a manufacturer of motion and control technologies and systems. The company offers critical motion and control solutions including fluid power systems, electromechanical controls and related components. Its products find use in various industries and ap …
  • BHG SA – Brazil Hospitality Group:企業の戦略・SWOT・財務分析
    BHG SA - Brazil Hospitality Group - Strategy, SWOT and Corporate Finance Report Summary BHG SA - Brazil Hospitality Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Enbridge Energy Partners LP (EEP):企業の財務・戦略的SWOT分析
    Enbridge Energy Partners LP (EEP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • President Energy PLC (PPC):石油・ガス:M&Aディール及び事業提携情報
    Summary President Energy PLC (President) is an independent oil and gas exploration and production company. It focuses mainly on Argentina and Paraguay in South America. The company has a diverse portfolio of operated onshore producing and exploration assets. Its major assets include working interest …
  • Bio2 Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Bio2 Medical Inc (Bio2 Medical) is a medical device company that develops vascular devices. The company’s products include angel catheter, an inferior vena cava filter for pulmonary embolism protection and access to the central venous system in critically ill patients. Its device is designed …
  • GW Pharmaceuticals Plc (GWPH):企業の財務・戦略的SWOT分析
    GW Pharmaceuticals Plc (GWPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Allergan Plc (AGN)-製薬・医療分野:企業M&A・提携分析
    Summary Allergan Plc (Allergan) is a specialty pharmaceutical company that develops and sells branded pharmaceuticals, biosimilar and over-the-counter (OTC) pharmaceutical products. It offers products in the areas of eye care, medical aesthetics, dermatology, central nervous system, gastroenterology …
  • Globo Comunicacao e Participacoes S.A.:企業の戦略的SWOT分析
    Globo Comunicacao e Participacoes S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Congenica Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Congenica Ltd (Congenica) is a biotechnology company that offers clinical decision support software and services. The company provides research and experimental development on biotechnology. Its technology SAPIENTIA is used to personalize patient care through accurate diagnoses, drug develop …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆